Actuate Therapeutics, Inc.
ACTU
$2.15
-$0.12-5.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -22.33% | 2.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.32% | -8.32% | |||
| Operating Income | 14.32% | 8.32% | |||
| Income Before Tax | 15.78% | 9.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.78% | 9.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.78% | 9.11% | |||
| EBIT | 14.32% | 8.32% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 23.39% | 16.55% | |||
| Normalized Basic EPS | 23.42% | 16.53% | |||
| EPS Diluted | 23.39% | 16.55% | |||
| Normalized Diluted EPS | 23.42% | 16.53% | |||
| Average Basic Shares Outstanding | 9.97% | 8.90% | |||
| Average Diluted Shares Outstanding | 9.97% | 8.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||